| Dr Brian Philip Defade, DO | |
|
1101 Saint Christopher Dr, Ashland, KY 41101-7087 | |
| (606) 833-3333 | |
| (606) 833-4668 |
| Full Name | Dr Brian Philip Defade |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 1101 Saint Christopher Dr, Ashland, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679764534 | NPI | - | NPPES |
| 3062680 | Medicaid | OH | |
| 000000665202 | Other | KY | ANTHEM BCBS |
| 7100120830 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 03268 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian Philip Defade, DO 1101 Saint Christopher Dr, Ashland, KY 41101-7087 Ph: (606) 833-3333 | Dr Brian Philip Defade, DO 1101 Saint Christopher Dr, Ashland, KY 41101-7087 Ph: (606) 833-3333 |
News Archive
Roche Molecular Systems, Inc. announced today a research collaboration with Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.) providing Merck access to Roche's developmental microarray-based AmpliChip p53 Test, which is designed to detect mutations in the tumor suppressor gene p53. By identifying cancers that harbor a dysfunctional p53 gene, the companies aim to achieve better treatment outcomes in cancer patients by determining which patients are most likely to respond to certain investigational therapeutic candidates.
In a new study led by researchers at Yale Cancer Center, the drug enfortumab vedotin (EV) significantly prolonged survival as compared with standard chemotherapy in patients with locally advanced or metastatic urothelial carcinoma or bladder cancer, who had previously received platinum-based treatment and a PD-1–PD-L1 inhibitor.
A key House GOP health policy writer has filed legislation to create a state-run health insurance exchange in Texas. A bill by Rep. John Zerwas, R-Katy, would create a Texas Health Insurance Connector, or simplified insurance market.
A project to help church communities become more 'dementia friendly' has had a significant impact across the country.
Many cardiac implantable electronic device models currently in use were approved via a Food and Drug Administration review process in which the models were assumed safe and effective based on approval of prior versions of the device, according to a study in the January 22/29 issue of JAMA.
› Verified 6 days ago
Dr. Justin Kevin Dixon, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 336 29th St, Ashland, KY 41101 Phone: 606-324-4404 Fax: 606-325-6822 | |
Timothy K Dixon, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 336 29th St, Ashland, KY 41101 Phone: 606-324-4404 Fax: 606-325-6822 | |
Edakkunny W Unnikrishnan, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 900 Saint Christopher Dr, Suite 201, Ashland, KY 41101 Phone: 606-836-2311 Fax: 606-836-3616 | |
Jeremy Bonzo, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 336 29th St Ste 101, Ashland, KY 41101 Phone: 606-324-4404 | |
Dr. William Charles Thorndyke, MDCM FRCS Urology Medicare: Accepting Medicare Assignments Practice Location: 336 29th St, Ashland, KY 41101 Phone: 606-324-4404 Fax: 606-325-6822 | |
William H Boykin Jr., M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 336 29th St, Ashland, KY 41101 Phone: 606-324-4404 Fax: 606-325-6822 |